Capricor Therapeutics
CAPR
#7318
Rank
A$0.82 B
Marketcap
A$14.23
Share price
9.44%
Change (1 day)
66.39%
Change (1 year)

EPS for Capricor Therapeutics (CAPR)

EPS in 2023 (TTM): A-$1.76

According to Capricor Therapeutics 's latest financial reports the company's current EPS (TTM) is A-$3.54. In 2022 the company made an earnings per share (EPS) of A-$1.70 a decrease over its 2021 EPS that were of A-$1.26.

EPS history for Capricor Therapeutics from 2001 to 2023

Annual EPS

Year EPS Change
2023 (TTM)A-$1.763.13%
2022A-$1.7035.63%
2021A-$1.26-7.45%
2020A-$1.36-55.45%
2019A-$3.05-59.81%
2018A-$7.58-1850%
2017A$0.43-102.94%
2016A-$14.7325.93%
2015A-$11.7055.77%
2014A-$7.51-39.53%
2013A-$12.42-64.78%
2012A-$35.26-62.44%
2011A-$93.89-31.58%
2010A-$137.22-38.71%
2009A-$223.88-43.64%
2008A-$397.21-5.17%
2007A-$418.88427.27%
2006A-$79.44340.33%
2005A-$18.04
2004N/A
2003N/A
2002N/A
2001N/A

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$9.66-372.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
A$10.18-387.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
A-$10.43 194.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
A-$6.28 77.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
A-$10.91 208.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
A-$42.31 1,095.51%๐Ÿ‡บ๐Ÿ‡ธ USA